Follow-up or Surveillance ¹⁸F-FDG PET/CT and Survival Outcome in Lung Cancer Patients

Abstract

(18)F-FDG PET/CT performed for follow-up more than 6 mo after the completion of primary treatment adds value to clinical judgment and is a prognostic marker of OS in lung cancer patients, regardless of the timing of the follow-up scan, and especially in patients younger than 70 y.